IL158549A0 - Smallpox vaccine - Google Patents

Smallpox vaccine

Info

Publication number
IL158549A0
IL158549A0 IL15854902A IL15854902A IL158549A0 IL 158549 A0 IL158549 A0 IL 158549A0 IL 15854902 A IL15854902 A IL 15854902A IL 15854902 A IL15854902 A IL 15854902A IL 158549 A0 IL158549 A0 IL 158549A0
Authority
IL
Israel
Prior art keywords
smallpox vaccine
smallpox
vaccine
Prior art date
Application number
IL15854902A
Other languages
English (en)
Original Assignee
Acambis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acambis Inc filed Critical Acambis Inc
Publication of IL158549A0 publication Critical patent/IL158549A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/275Poxviridae, e.g. avipoxvirus
    • A61K39/285Vaccinia virus or variola virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24161Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15854902A 2001-04-23 2002-04-23 Smallpox vaccine IL158549A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/840,751 US6723325B1 (en) 2001-04-23 2001-04-23 Smallpox vaccine
PCT/US2002/012616 WO2002085411A1 (en) 2001-04-23 2002-04-23 Smallpox vaccine

Publications (1)

Publication Number Publication Date
IL158549A0 true IL158549A0 (en) 2004-05-12

Family

ID=25283120

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15854902A IL158549A0 (en) 2001-04-23 2002-04-23 Smallpox vaccine
IL158549A IL158549A (en) 2001-04-23 2003-10-22 Smallpox vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158549A IL158549A (en) 2001-04-23 2003-10-22 Smallpox vaccine

Country Status (20)

Country Link
US (2) US6723325B1 (cs)
EP (1) EP1381389B1 (cs)
JP (1) JP4397591B2 (cs)
KR (1) KR20040063083A (cs)
CN (1) CN1527722A (cs)
AU (1) AU2002258910B2 (cs)
BR (1) BR0209145A (cs)
CA (1) CA2444747C (cs)
CZ (1) CZ305819B6 (cs)
EA (1) EA007656B1 (cs)
ES (1) ES2546612T3 (cs)
HK (1) HK1062804A1 (cs)
HU (1) HU228401B1 (cs)
IL (2) IL158549A0 (cs)
MA (1) MA26270A1 (cs)
MX (1) MXPA03009711A (cs)
NZ (1) NZ529265A (cs)
PL (1) PL212117B1 (cs)
WO (1) WO2002085411A1 (cs)
ZA (1) ZA200309084B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723325B1 (en) * 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine
US7645456B2 (en) * 2001-04-23 2010-01-12 Sanofi Pasteur Biologics Co. Vaccinia virus strains
WO2006113927A2 (en) * 2005-04-20 2006-10-26 University Of Washington Immunogenic vaccinia peptides and methods of using same
RU2541784C2 (ru) * 2006-11-07 2015-02-20 Санофи Пастер Байолоджикс Ко. Лиофилизированная композиция для индукции иммунного ответа на флавивирус, композиция и способ для ее получения
KR100859345B1 (ko) * 2006-12-12 2008-09-19 씨제이제일제당 (주) 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신
WO2012142529A2 (en) * 2011-04-15 2012-10-18 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof
RU2496149C1 (ru) * 2012-06-19 2013-10-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ оценки противооспенной активности лечебно-профилактических препаратов
AU2017353868C1 (en) 2016-11-02 2024-06-06 David Evans Synthetic chimeric poxviruses
US11505782B2 (en) 2018-06-04 2022-11-22 Calidi Biotherapeutics, Inc. Cell-based vehicles for potentiation of viral therapy
CA3177862A1 (en) 2018-11-06 2020-05-14 Calidi Biotherapeutics, Inc. Enhanced systems for cell-mediated oncolytic viral therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
US5614193A (en) * 1991-11-14 1997-03-25 The United States Of America As Represented By The Secretary Of The Army Hantavirus vaccine
US5656465A (en) * 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US6723325B1 (en) * 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine

Also Published As

Publication number Publication date
ES2546612T3 (es) 2015-09-25
CN1527722A (zh) 2004-09-08
EP1381389A1 (en) 2004-01-21
EP1381389A4 (en) 2004-07-28
EP1381389B1 (en) 2015-08-26
PL373958A1 (en) 2005-09-19
HUP0303878A3 (en) 2010-01-28
ZA200309084B (en) 2005-01-26
BR0209145A (pt) 2005-04-19
NZ529265A (en) 2006-04-28
CA2444747A1 (en) 2002-10-31
CZ305819B6 (cs) 2016-03-30
CZ20033184A3 (cs) 2004-04-14
US6723325B1 (en) 2004-04-20
PL212117B1 (pl) 2012-08-31
AU2002258910B2 (en) 2007-10-25
EA007656B1 (ru) 2006-12-29
EA200301151A1 (ru) 2004-10-28
US7115270B2 (en) 2006-10-03
WO2002085411A1 (en) 2002-10-31
HK1062804A1 (en) 2004-11-26
JP2005503126A (ja) 2005-02-03
US20060153873A1 (en) 2006-07-13
CA2444747C (en) 2018-04-17
JP4397591B2 (ja) 2010-01-13
IL158549A (en) 2009-07-20
MXPA03009711A (es) 2005-03-07
HU228401B1 (en) 2013-03-28
HUP0303878A2 (hu) 2004-03-01
KR20040063083A (ko) 2004-07-12
MA26270A1 (fr) 2004-09-01

Similar Documents

Publication Publication Date Title
HUP0402471A3 (en) Vaccine
IL227966A0 (en) Vaccination kit
GB0407935D0 (en) Vaccine
GB0103170D0 (en) Vaccine composition
GB0103171D0 (en) Vaccine composition
HUP0402259A3 (en) Vaccines
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) VACCINE
GB0306611D0 (en) Novel vaccine
GB0121171D0 (en) Vaccine
IL158549A0 (en) Smallpox vaccine
IL158124A0 (en) Leishmania vaccines
EP1428879A4 (en) polynucleotide vaccine
GB0105238D0 (en) Vaccines
AU2002347346A8 (en) Dna vaccine
GB0128733D0 (en) Fowlpox vaccine
GB0103867D0 (en) Vaccine
GB0106589D0 (en) Vaccine
GB0130823D0 (en) Vaccine
GB0128312D0 (en) Vaccine
GB0124137D0 (en) Vaccine
GB0115496D0 (en) Vaccine
GB0107511D0 (en) Novel vaccine
GB0104538D0 (en) Novel Vaccine
GB0104542D0 (en) Novel vaccine